Among a variety of immune cells in the tumor microenvironment, we found that the number of CD8+ CTLs was significantly lower in Regnase-1-deficient orthotopic KPC tumors than in Regnase-1-proficient tumors (Fig. 6A-D). The gene discussed is CD8A; the disease is neoplasm.